API determination by NIR spectroscopy across pharmaceutical production process

AAPS PharmSciTech

Volumn 9, Issue 4, 2008, Pages 1130-1135

  Blanco, Marcel ^a   Bautista, M ^a   Alcala M ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

API determination; NIR spectroscopy; PAT; PLS calibration; Tablet content uniformity

Indexed keywords

DEXKETOPROFEN; EXCIPIENT; MICROCRYSTALLINE CELLULOSE;

ARTICLE; CALIBRATION; DRUG COATING; DRUG FORMULATION; DRUG GRANULATION; DRUG MANUFACTURE; DRUG MIXTURE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; PROCESS MODEL; QUANTITATIVE ANALYSIS; SOLID; CHEMISTRY; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; REGRESSION ANALYSIS; TABLET; VALIDATION STUDY;

CALIBRATION; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; LEAST-SQUARES ANALYSIS; SPECTROSCOPY, NEAR-INFRARED; TABLETS;

EID: 63649156905     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9156-3     Document Type: Article

References (14)

1. Guidance for Industry. PAT - A framework for innovative pharmaceutical development, manufacturing, and quality Assurance. US Department of Health and Human Services, Food and Drug Administration, Center of Drug Evaluation (CDER), and Research, Center for Veterinary Medicine (CVM), Office of Regulatory Affairs (ORA), 2004.
2. S. Kueppers, and M. Haider. Process analytical chemistry - future trends in industry. Anal. Bioanal. Chem. 376:313-315 (2003).
3. P. Chalus, Y. Roggoa, S. Walter, and M. Ulmschneider. Near-infrared determination of active substance content in intact low-dosage tablets. Talanta. 66:1294-1302 (2005).
4. M. Blanco, and M. Alcala. Content uniformity and tablet hardness testing of intact pharmaceutical tablets by near infrared spectroscopy A contribution to process analytical technologies. Anal. Chim. Acta. 557:353-359 (2006).
5. M. Blanco, M. Alcalá, J. M. González, and E. Torras. A process analytical technology approach based on near infrared spectroscopy: Tablet hardness, content uniformity, and dissolution test measurements of intact tablets. J. Pharm. Sci. 95:2137-2144 (2006).
6. C. Peroza, M. A. Santos, and R. J. Romañach. Quantitation of drug content in a low dosage formulation by transmission near infrared spectroscopy. AAPS Pharm. Sci, Tech. 7(1) (2006), Article 29.
7. C. Sajeev, P. R. Jadhav, D. RaviShankar, and R. N. Saha. Determination of flurbiprofen in pharmaceutical formulations by UV spectrophotometry and liquid chromatography. Anal. Chim. Acta. 463:207-217 (2002).
8. A. Abourashed, and A. Khan. High-performance liquid chromatography determination of hydrastine and berberine in dietary supplements containing goldenseal. J. Pharm. Sci. 90:7817-822 (2001).
9. M. Donoso, D. O. Kildsig, and E. S. Ghaly. Prediction of tablet hardness and porosity using near-infrared diffuse reflectance spectroscopy as a nondestructive method. Pharm. Dev. Tech. 8:357-366 (2003).
10. A. C. Peinado, F. van den Berg, M. Blanco, and R. Bro. Temperature-induced variation for NIR tensor-based calibration. Chemom. Intel. Lab. Sys. 83:75-82 (2006).
11. M. Blanco, and M. Alcala. Use of near-infrared spectroscopy for off-line measurements in the pharmaceutical industry. In K. Bakeev (ed.), Process Analytical Technology, Blackwell, Oxford, 2005, pp. 375-376.
12. M. W. Scheiwe, D. Schilling, and P. Aebi. Near Infrared spectroscopy analysis of intact diclofenac coated tablets in transmission. Pharmazeutische Industrie. 61:179-183 (1999).
13. ICH Q2B: Validation of Analytical procedures: Methodology, Consensus Guideline, International Conference on Harmonisation (ICH), 1998. http://www.bcg-usa.com/docs/ich/ICHQ2B.pdf
14. Note for guidance on the use of near infrared spectroscopy by the pharmaceutical industry and the data requirements for new submissions and variations, 2003. http://www.fda.gov/Cber/gdlns/cmprprot.pdf